Optometry - Journal of the American Optometric Association
Volume 78, Issue 4 , Pages 162-166 , April 2007

Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma

  • Laura A. Falco, O.D.

      Affiliations

    • College of Optometry, Nova Southeastern University, Fort Lauderdale, Florida
    • Corresponding Author InformationCorresponding author: Laura A. Falco, O.D., Nova SE University, College of Optometry, 3200 University Drive, Terry Building, 4th Floor Optometry, Fort Lauderdale, Florida 33328.
    • ,
  • Paul J. Gruosso, O.D.

      Affiliations

    • Bay Pines VA Hospital, Bay Pines, Florida
    • ,
  • Keith Skolnick, M.D.

      Affiliations

    • Fort Lauderdale Eye Institute, Fort Lauderdale, Florida.
    • ,
  • Lorena Bejar, O.D.

      Affiliations

    • College of Optometry, Nova Southeastern University, Fort Lauderdale, Florida

References 

  1. Shields J, Shields C. Tumors of conjunctiva and cornea. Surv Ophthalmol. 2004;49:3–24
  2. Sjo NC, Heegaard S, Prause JU, et al. Human papillomavirus in conjunctival papilloma. Br J Ophthalmol. 2001;85:785–787
  3. Lauer SA, Malter JS, Meier JR. Human papillomavirus type 18 in conjunctival intraepithelial neoplasia. Am J Ophthalmol. 1990;110:23–27
  4. McDonnell JM, McDonnell PJ, Sun YY. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci. 1992;33:184–189
  5. Reszed J, Sulkowski S. The expression of P53 protein and infection of human papilloma virus in conjunctival and eyelid neoplasms. Int J Mol Med. 2005;16(4):559–564
  6. Khong JJ, Muecke J. Complication of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol. 2006;90(7):819–822
  7. Prabhasawat P, Tarinvorakukp P, Tesavibul N, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005;24(4):443–448
  8. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601–606
  9. Karp C, Moore J, Rosa R. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon ά 2 β. Ophthalmology. 2001;108(6):1093–1098
  10. Boehm M, Huang A. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon ά 2 β. Ophthalmology. 2004;111(9):1755–1761
  11. Schechter B, Rand W, Velazquez G, et al. Treatment of conjunctival papillomata with topical interferon ά 2 β. Am J Ophthalmol. 2002;134(2):268–270
  12. Chen HC, Chang SW, Huang SF. Adjunctive treatment with interferon alpha–2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence. Cornea. 2004;23(7):726–729
  13. Digital Reference of Ophthalmology. Cornea and external diseases, infectious. Available at: http://dro.hs.columbia.edu/phlyctenular/htm. Last accessed October 12, 2006.
  14. Handbook of Ocular Disease Management. Phlyctenulosis (phlyctenular keratoconjunctivitis). Available at: http://revoptom.com/handbook/March_2004/sec2_5.htm. Last accessed October 12, 2006.
  15. The Merck Manual. Phylctenular keratoconjunctivitis (phlyctenular conjunctivitis phlyctenulosis). Available at: http://mrkshared/mmanual/section8/chapter96/96f.jsp. Last accessed October 12, 2006.

PII: S1529-1839(07)00049-8

doi: 10.1016/j.optm.2006.10.017

Optometry - Journal of the American Optometric Association
Volume 78, Issue 4 , Pages 162-166 , April 2007

Article Tools

* Image Usage & Resolution